Jazz Pharmaceuticals JAZZ Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 2×-1.3× | 1.9×-2.6× | 1.7×-2.6× | 1.6×-0.7× | 3.4×+1.1× | |
| Leverage | ||||||
| Debt-to-equity | 1.2×-0.1× | 1.3×-0.2× | 1.4×-0.1× | 1.5×-0.1× | 1.3×-0.3× | |
| Per Share | ||||||
| Book value per share | $68.57+0.2% | $70.82+14.2% | $64.26-2.7% | $60.57+12.1% | $68.44+15.8% | |
| Valuation | ||||||
| Market capitalization | $11.64B+54.4% | $10.33B+38.8% | $7.99B+14.1% | $6.54B-2.0% | $7.54B+0.1% | |
| Price / sales | 2.6×+0.8× | 2.4×+0.6× | 1.9×+0.2× | 1.6×-0.1× | 1.9×-0.1× | |
| Price / book | 2.6×+0.8× | 2.4×+0.6× | 2×+0.3× | 1.8×0.0× | 1.8×-0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Jazz Pharmaceuticals's ratios come from?
- Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
